These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of high blood cholesterol in patients with coronary heart disease]. Nagai Y; Yamashita S Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049 [No Abstract] [Full Text] [Related]
3. Aggressive lipid therapy in the statin era. Farmer JA Prog Cardiovasc Dis; 1998; 41(2):71-94. PubMed ID: 9790411 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy. Hunninghake DB Am J Med; 1998 Feb; 104(2A):9S-13S. PubMed ID: 9550501 [TBL] [Abstract][Full Text] [Related]
5. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
6. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare? Gotto AM; Kuller LH Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688 [No Abstract] [Full Text] [Related]
7. Reduction of coronary events: evidence from clinical trials. Gotto AM Curr Opin Lipidol; 1995 Dec; 6(6):345-7. PubMed ID: 8750245 [No Abstract] [Full Text] [Related]
8. Intensive cholesterol lowering: no longer a myth. Bitzur R; Harats D Isr Med Assoc J; 2005 Dec; 7(12):816-7. PubMed ID: 16382708 [No Abstract] [Full Text] [Related]
9. Novel approaches to lipid lowering: what is on the horizon? Brown WV Am J Cardiol; 2001 Mar; 87(5A):23B-27B. PubMed ID: 11256846 [TBL] [Abstract][Full Text] [Related]
10. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre. Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of high blood cholesterol in patients with coronary heart disease]. Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661 [No Abstract] [Full Text] [Related]
13. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]
14. The new National Cholesterol Education Program guidelines: clinical challenges for more widespread therapy of lipids to treat and prevent coronary heart disease. Eidelman RS; Lamas GA; Hennekens CH Arch Intern Med; 2002 Oct; 162(18):2033-6. PubMed ID: 12374510 [No Abstract] [Full Text] [Related]
15. Do patients on statins also need niacin? Jones KW JAAPA; 2013 Jul; 26(7):9-10. PubMed ID: 23923280 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG Am J Cardiol; 2003 Mar; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338 [TBL] [Abstract][Full Text] [Related]
17. [Guideline for management of lipid metabolism]. Ishibashi S Nihon Rinsho; 2002 Sep; 60 Suppl 9():675-8. PubMed ID: 12387068 [No Abstract] [Full Text] [Related]
18. [Letter on the article: "Which lipid profiles and how to interpret in patients with coronary heart disease?"]. Ambrosi P Presse Med; 2010 Feb; 39(2):286-7. PubMed ID: 20074902 [No Abstract] [Full Text] [Related]
19. [A new approach to the treatment of dyslipidemia]. Kevelaitiene S; Slapikas R Medicina (Kaunas); 2008; 44(5):407-13. PubMed ID: 18541958 [TBL] [Abstract][Full Text] [Related]